FKBP5 and neoplasm: The survival curve with the best prognosis includes individuals whose tumors show a level of positivity for FKBP51 rated from 0%–10%; the intermediate outcome is attributed to levels of positivity for the marker from 11%–50%; while a higher value of 51% positive tumor cells is sufficient to identify the group of patients with the worst prognosis at follow-up.